377 related articles for article (PubMed ID: 15755806)
1. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.
Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806
[TBL] [Abstract][Full Text] [Related]
2. Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome.
Akeson EC; Lambert JP; Narayanswami S; Gardiner K; Bechtel LJ; Davisson MT
Cytogenet Cell Genet; 2001; 93(3-4):270-6. PubMed ID: 11528125
[TBL] [Abstract][Full Text] [Related]
3. Understanding mental retardation in Down's syndrome using trisomy 16 mouse models.
Galdzicki Z; Siarey RJ
Genes Brain Behav; 2003 Jun; 2(3):167-78. PubMed ID: 12931790
[TBL] [Abstract][Full Text] [Related]
4. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
5. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.
Kahlem P; Sultan M; Herwig R; Steinfath M; Balzereit D; Eppens B; Saran NG; Pletcher MT; South ST; Stetten G; Lehrach H; Reeves RH; Yaspo ML
Genome Res; 2004 Jul; 14(7):1258-67. PubMed ID: 15231742
[TBL] [Abstract][Full Text] [Related]
6. Segmental trisomy of mouse chromosome 17: introducing an alternative model of Down's syndrome.
Forejt J; Vacík T; Gregorová S
Comp Funct Genomics; 2003; 4(6):647-52. PubMed ID: 18629032
[TBL] [Abstract][Full Text] [Related]
7. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ
Pediatr Res; 2000 Nov; 48(5):606-13. PubMed ID: 11044479
[TBL] [Abstract][Full Text] [Related]
8. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
[TBL] [Abstract][Full Text] [Related]
9. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.
Lyle R; Gehrig C; Neergaard-Henrichsen C; Deutsch S; Antonarakis SE
Genome Res; 2004 Jul; 14(7):1268-74. PubMed ID: 15231743
[TBL] [Abstract][Full Text] [Related]
10. Developmental consequences of autosomal aneuploidy in mammals.
Gearhart JD; Oster-Granite ML; Reeves RH; Coyle JT
Dev Genet; 1987; 8(4):249-65. PubMed ID: 2971493
[TBL] [Abstract][Full Text] [Related]
11. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
Granholm AC; Sanders LA; Crnic LS
Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084
[TBL] [Abstract][Full Text] [Related]
12. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome.
Richtsmeier JT; Zumwalt A; Carlson EJ; Epstein CJ; Reeves RH
Am J Med Genet; 2002 Feb; 107(4):317-24. PubMed ID: 11840489
[TBL] [Abstract][Full Text] [Related]
13. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.
Blazek JD; Billingsley CN; Newbauer A; Roper RJ
Dev Dyn; 2010 Jun; 239(6):1645-53. PubMed ID: 20503361
[TBL] [Abstract][Full Text] [Related]
14. Developmental instability of the cerebellum and its relevance to Down syndrome.
Shapiro BL
J Neural Transm Suppl; 2001; (61):11-34. PubMed ID: 11771737
[TBL] [Abstract][Full Text] [Related]
15. Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosome.
Xing Z; Li Y; Cortes-Gomez E; Jiang X; Gao S; Pao A; Shan J; Song Y; Perez A; Yu T; Highsmith MR; Boadu F; Conroy JM; Singh PK; Bakin AV; Cheng J; Duan Z; Wang J; Liu S; Tycko B; Yu YE
Hum Mol Genet; 2023 Jun; 32(13):2205-2218. PubMed ID: 37014740
[TBL] [Abstract][Full Text] [Related]
16. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome.
Sussan TE; Yang A; Li F; Ostrowski MC; Reeves RH
Nature; 2008 Jan; 451(7174):73-5. PubMed ID: 18172498
[TBL] [Abstract][Full Text] [Related]
17. Structural variation of chromosome 21 and symptoms of Down's syndrome.
Rethoré MO
Hum Genet Suppl; 1981; 2():173-82. PubMed ID: 6218134
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development.
Potier MC; Rivals I; Mercier G; Ettwiller L; Moldrich RX; Laffaire J; Personnaz L; Rossier J; Dauphinot L
J Neurochem; 2006 Apr; 97 Suppl 1():104-9. PubMed ID: 16635258
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.
Reinholdt LG; Ding Y; Gilbert GJ; Czechanski A; Solzak JP; Roper RJ; Johnson MT; Donahue LR; Lutz C; Davisson MT
Mamm Genome; 2011 Dec; 22(11-12):685-91. PubMed ID: 21953412
[TBL] [Abstract][Full Text] [Related]
20. Mouse models of Down syndrome: gene content and consequences.
Gupta M; Dhanasekaran AR; Gardiner KJ
Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
